Schmidt, Signe http://orcid.org/0000-0002-6968-6675
Madsen, Kristoffer Panduro
Pedersen-Bjergaard, Ulrik
Rytter, Karen
Hommel, Eva
Cleal, Bryan
Willaing, Ingrid
Andersen, Henrik Ullits
Nørgaard, Kirsten
Funding for this research was provided by:
Royal Library, Copenhagen University Library
Article History
Received: 4 January 2023
Accepted: 28 March 2023
First Online: 9 May 2023
Declarations
:
: S.S. has received lecture fees from Novo Nordisk and is an employee of Novo Nordisk A/S since May 1st, 2022. K.P.M. is shareholder in Novo Nordisk. U.P-B has received lecture fees from and has served as an adviser for Novo Nordisk and Sanofi. K.R. is shareholder in Novo Nordisk and has received lecture fees from Medtronic. E.H. is shareholder in Novo Nordisk. B.C. has nothing to declare. I.W. is shareholder in Novo Nordisk. H.U.A. is shareholder in Novo Nordisk and has served as an adviser to Abbott and Sanofi. K.N. is a shareholder in Novo Nordisk, has served as an adviser to Medtronic, Abbott, Convatec and Novo Nordisk, has received research grants from Novo Nordisk, Medtronic, Dexcom, Zealand Pharma and Roche Diabetes Care, and has received lecture fees from Medtronic, Dexcom, Roche Diabetes Care, Novo Nordisk, Zealand Pharma, and Sanofi.